Emtriva
NDC 61958-0602, EMTRICITABINE, solution, from Gilead Sciences, Inc..
- Product NDC
- 61958-0602
- Status
- Listed
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021896
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61958-0602 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EMTRICITABINE10 mg/mL
Pharmacologic classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61958-0602-1 | 61958060201 | 1 BOTTLE, DISPENSING in 1 CARTON (61958-0602-1) / 170 mL in 1 BOTTLE, DISPENSING |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d6599395-3944-44f9-97f2-e0424c6b6a1f
Use it
Look up 61958-0602 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61958-0602 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61958-0602. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.